Cause of Anemia in a Patient with Decompensated Chronic Liver Disease

Hemolytic Anemia in Liver Disease

The patient's anemia is most likely due to microangiopathic hemolytic anemia (MAHA) secondary to decompensated chronic liver disease, with the presence of schistocytes confirming intravascular hemolysis 1, 2
Decompensated chronic liver disease causes microangiopathic hemolytic anemia through several mechanisms, including elevated bilirubin levels directly triggering eryptosis, indirect hyperbilirubinemia indicating ongoing hemolysis, and microangiopathic changes in the hepatic vasculature causing mechanical damage to red blood cells 3, 4
The presence of schistocytes on peripheral smear is pathognomonic for microangiopathic hemolytic anemia, indicating mechanical fragmentation of red blood cells 1, 2
Indirect hyperbilirubinemia reflects increased red cell destruction with release of unconjugated bilirubin 3, 4
Laboratory findings typically include elevated lactate dehydrogenase (LDH) 2

Multiple intramuscular hematomas occur due to the complex coagulopathy of liver disease, including decreased synthesis of clotting factors, thrombocytopenia from splenic sequestration, dysfibrinogenemia, and accelerated fibrinolysis 5
Phosphatidylserine exposure on hemolyzed red blood cells affects coagulation, with studies showing shortened coagulation times initially due to procoagulant activity of exposed phosphatidylserine, and subsequent consumption of clotting factors leading to bleeding tendency 4, 5
The combination of hemolysis and liver dysfunction creates a paradoxical state where both thrombosis (microangiopathy) and bleeding (hematomas) can occur 5

Thrombotic thrombocytopenic purpura (TTP) should be considered as a differential diagnosis, characterized by more severe thrombocytopenia and neurological symptoms 1, 2
Disseminated intravascular coagulation (DIC) may coexist with liver disease, showing more pronounced thrombocytopenia and elevated fibrin degradation products 5

Coagulation studies, including PT, PTT, fibrinogen, and D-dimer, are essential in managing patients with decompensated chronic liver disease and hemolytic anemia 5
Correcting coagulopathy with fresh frozen plasma or prothrombin complex concentrate is recommended for active bleeding 5